Arxis adds Omnetics financials after acquisition
The added statements show Omnetics’ standalone results and provide illustrative combined income figures for 2025 and the first nine months of 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Arxis, Inc. (ARXS) added Omnetics Connector Corporation’s audited and interim financial statements and illustrative combined results after completing the acquisition on August 17, 2026. The agreed enterprise value was $770.0 million, subject to customary closing adjustments. Arxis issued 13,351,964 Class A shares to Omnetics’ former shareholders and funded $8.0 million of cash escrow accounts. Preliminary consideration transferred was $777,074,416.
Omnetics reported 2025 net sales of $113.5 million and net income attributable to Omnetics of $22.9 million. For the six months ended June 30, 2026, it reported net sales of $66.5 million and net income attributable to Omnetics of $14.4 million. These figures describe Omnetics on a standalone basis.
Pro forma combined revenue and net income were $1,608.345 million and $145.954 million for the nine months ended September 30, 2026, and $1,704.538 million and $46.307 million for 2025. The pro forma statements treat the merger as if it occurred January 1, 2025; they are illustrative and exclude potential revenue and operating synergies and cost savings.
How this balance works
Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.
It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.
Rhea-AI Sentiment measures something else, the tone of the wording.
Positive
- Moderate pointOmnetics acquisition closed August 17, 2026; preliminary consideration transferred was $777,074,416. 3.3% of market cap
Negative
- None.
Filing Explained
The completed deal’s 13,351,964 issued shares reduce existing holders’ ownership percentages, while acquired intangibles add amortization to pro forma results.
This amendment adds a preliminary purchase-price allocation for the completed Omnetics acquisition:
Pro forma basic and diluted earnings per share are
The purchase-price allocation remains preliminary; the filing says differences between the preliminary and final allocation may cause actual results to differ from the pro forma amounts.
8-K Event Classification
Key Figures
Key Terms
enterprise value financial
acquisition method of accounting financial
preliminary purchase price allocation financial
goodwill financial
two-class method financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
How much was Arxis’ acquisition of Omnetics?
What were Omnetics’ reported financial results?
What was included in Omnetics’ preliminary purchase price allocation?
AI-generated analysis. How Rhea-AI works. Not financial advice.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K/A
(Amendment No. 1)
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): |
(Exact name of Registrant as Specified in Its Charter)
(State or Other Jurisdiction |
(Commission File Number) |
(IRS Employer |
||
|
|
|
|
|
|
||||
|
||||
(Address of Principal Executive Offices) |
|
(Zip Code) |
||
Registrant’s Telephone Number, Including Area Code: |
|
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Securities registered pursuant to Section 12(b) of the Act:
|
|
Trading |
|
|
|
|
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Explanatory Note
On August 18, 2026, Arxis, Inc. (the “Company”) filed a Current Report on Form 8-K (the "Initial 8-K") with the Securities and Exchange Commission (the "SEC") disclosing that on August 17, 2026, the Company closed on the transactions contemplated by the Agreement and Plan of Merger (the “Merger”) with Orion Merger Sub, Inc., a Minnesota corporation and a wholly owned subsidiary of Arxis (the “Merger Sub”), Omnetics Connector Corporation, a Minnesota corporation (“Omnetics”), and Gary Jacobs, President of Omnetics, in his capacity as shareholder representative (the “Shareholder Representative”), entered into on May 29, 2026 (the "Merger Agreement"). The aggregate consideration for the Merger was based on an agreed enterprise value, which was $770.0 million, subject to customary closing adjustments. At closing, the Company issued 13,351,964 shares of the Company’s Class A common stock, par value $0.01 per share (“Class A common stock”), to the former shareholders of Omnetics and funded $8.0 million of cash escrow accounts pursuant to the Merger Agreement. The issuance of the Company’s Class A common stock was made pursuant to an exemption from registration under Section 4(a)(2) of the Securities Act of 1933.
This Amendment No. 1 (this “Amendment”) amends the Initial 8-K to file the financial statements and pro forma financial information required by Items 9.01(a) and (b) of Form 8-K to be filed by amendment no later than 71 calendar days after the date on which the Initial 8-K was required to be filed. This Amendment should be read in conjunction with the Initial 8-K and the Company’s other filings with the SEC. Except as stated herein, this Amendment does not reflect events occurring after the filing of the Initial 8-K with the SEC on August 18, 2026 and no attempt has been made in this Amendment to modify or update other information as disclosed in the Initial 8-K.
Item 9.01 Financial Statements and Exhibits.
(a) Financial statements of business acquired.
(b) Pro forma financial information.
The unaudited pro forma combined statements of income of the Company for the nine months ended September 30, 2026 and for the year ended December 31, 2025, giving pro forma effect to the Company's acquisition of all outstanding equity securities of Omnetics, and the notes related thereto are filed as Exhibit 99.4 hereto and are incorporated herein by reference.
(d) Exhibits.
Exhibit No. |
|
|
23.1** |
|
Consent of Boulay PLLP |
99.1* |
|
Press Release dated August 18, 2026 (incorporated by reference to Exhibit 99.1 of the Company's Current Report on Form 8-K filed with the SEC on August 18, 2026) |
99.2** |
|
Omnetics Connector Corporation December 31, 2025 Audited Consolidated Financial Statements |
99.3** |
|
Omnetics Connector Corporation June 30, 2026 Unaudited Condensed Consolidated Financial Statements |
99.4** |
|
Arxis, Inc. Unaudited Pro Forma Financial Information |
104 |
|
Cover Page Interactive Data File (embedded within the Inline XBRL document) |
__________________________
* Previously filed.
** Filed herewith.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
|
Arxis, Inc. |
|
|
|
|
Date: |
October 29, 2026 |
By: |
/s/ Azad Badakhsh |
|
|
|
Azad Badakhsh |
Exhibit 99.2
Omnetics Connector Corporation
Table of Contents
Independent Auditor's Report |
1-2 |
Consolidated Financial Statements |
|
Consolidated Balance Sheet |
3 |
Consolidated Statement of Operations and Comprehensive Income |
4 |
Consolidated Statement of Changes in Stockholders' Equity |
5 |
Consolidated Statement of Cash Flows |
6 |
Notes to the Consolidated Financial Statements |
7-15 |

Independent Auditor's Report
To the Board of Directors and Stockholders
Omnetics Connector Corporation
Minneapolis, Minnesota
Opinion
We have audited the accompanying consolidated financial statements of Omnetics Connector Corporation (the "Company"), which comprise the consolidated balance sheet as of December 31, 2025, and the related consolidated statements of operations and comprehensive income, changes in stockholders' equity and cash flows for the year then ended, and the related notes to the consolidated financial statements.
In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the financial position of the Company as of December 31, 2025, and the results of its operations and its cash flows for the year then ended in accordance with accounting principles generally accepted in the United States of America.
Basis for Opinion
We conducted our audit in accordance with auditing standards generally accepted in the United States of America. Our responsibilities under those standards are further described in the Auditor's Responsibilities for the Audit of the Consolidated Financial Statements section of our report. We are required to be independent of the Company and to meet our other ethical responsibilities in accordance with the relevant ethical requirements relating to our audit. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our audit opinion.
Responsibilities of Management for the Consolidated Financial Statements
Management is responsible for the preparation and fair presentation of these consolidated financial statements in accordance with accounting principles generally accepted in the United States of America and for the design, implementation, and maintenance of internal control relevant to the preparation and fair presentation of consolidated financial statements that are free from material misstatement, whether due to fraud or error.
In preparing the consolidated financial statements, management is required to evaluate whether there are conditions or events, considered in the aggregate, that raise substantial doubt about the Company's ability to continue as a going concern within one year after the date that the consolidated financial statements are available to be issued.
Auditor's Responsibilities for the Audit of the Consolidated Financial Statements
Our objectives are to obtain reasonable assurance about whether the consolidated financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor's report that includes our opinion. Reasonable assurance is a high level of assurance but is not absolute assurance and therefore is not a guarantee that an audit conducted in accordance with generally accepted auditing standards will always detect a material misstatement when it exists. The risk of not detecting a material misstatement resulting from fraud is higher than for one resulting from error, as fraud may involve collusion, forgery, intentional omissions, misrepresentations, or the override of internal control. Misstatements are considered material if there is a substantial likelihood that, individually or in aggregate, they would influence the judgment made by a reasonable user based on the consolidated financial statements.
MN Eden Prairie | Mankato | Minneapolis
BoulayGroup.com (t) 952.893.9320
1
Independent Auditor's Report
In performing an audit in accordance with generally accepted auditing standards, we:
We are required to communicate with those charged with governance regarding, among other matters, the planned scope and timing of the audit, significant audit findings, and certain internal control related matters that we identified during the audit.
Minneapolis, Minnesota October 29, 2026
2
Omnetics Connector Corporation
Consolidated Balance Sheet
|
December 31, 2025 |
|
Assets |
|
|
Current assets: |
|
|
Cash and cash equivalents |
$ |
28,736,058 |
Marketable securities |
|
19,171,084 |
Trade accounts receivable |
|
13,023,878 |
Inventories, net |
|
39,786,216 |
Prepaid assets |
|
960,964 |
Total current assets |
|
101,678,200 |
Long-term marketable securities |
|
26,832,766 |
Property and equipment, net |
|
7,985,796 |
Deferred income taxes |
|
456,000 |
Goodwill |
|
1,039,000 |
Operating lease right-of-use asset |
|
5,409,766 |
Other assets |
|
88,744 |
Total Assets |
$ |
143,490,272 |
Liabilities and Stockholders' Equity |
|
|
Current liabilities: |
|
|
Trade accounts payable |
$ |
2,053,869 |
Accrued expenses |
|
7,657,973 |
Operating lease liability |
|
292,547 |
Total current liabilities |
|
10,004,389 |
Long-term portion of operating lease liability |
|
6,260,197 |
Total liabilities |
|
16,264,586 |
Stockholders' equity |
|
|
Common stock, $.01 par value; 1,000,000 shares authorized, 618,831 shares issued and outstanding at December 31, 2025 |
|
6,188 |
Additional paid-in capital |
|
60,433 |
Retained earnings |
|
124,919,365 |
Accumulated other comprehensive income |
|
449,513 |
Total stockholders' equity attributable to Omnetics Connector Corporation |
|
125,435,499 |
Noncontrolling interest - Omnetics, LLC |
|
1,790,187 |
Total stockholders' equity |
|
127,225,686 |
Total Liabilities and Stockholders' Equity |
$ |
143,490,272 |
The accompanying notes are an integral part of these consolidated financial statements.
3
Omnetics Connector Corporation
Consolidated Statement of Operations and Comprehensive Income
|
Year Ended December 31, 2025 |
|
Net sales |
$ |
113,518,473 |
Cost of products sold |
|
64,588,339 |
Gross profit |
|
48,930,134 |
Selling, general and administrative expenses |
|
15,947,527 |
Operating income |
|
32,982,607 |
Other income |
|
2,028,874 |
Income before provision for income taxes |
|
35,011,481 |
Provision for income taxes |
|
7,535,000 |
Net income |
|
27,476,481 |
Less: net income attributable to noncontrolling interest - Omnetics, LLC |
|
4,592,551 |
Net income attributable to Omnetics Connector Corporation |
|
22,883,930 |
Other Comprehensive Income: |
|
|
Unrealized holding gains on marketable securities, net of tax |
|
543,455 |
Less reclassification of gains on marketable securities included in net income, net of tax |
|
(4,847) |
Total other comprehensive income |
|
538,608 |
Comprehensive income attributable to Omnetics Connector Corporation |
$ |
23,422,538 |
The accompanying notes are an integral part of these consolidated financial statements.
4
Omnetics Connector Corporation
Consolidated Statement of Changes in Stockholders' Equity
|
Common Stock Shares |
|
Common Stock Par Value |
|
Additional Paid-in Capital |
|
Retained Earnings |
|
Accumulated Other Comprehensive Income (Loss) |
|
Total Stockholders' Equity - OCC |
|
Noncontrolling Interest – Omnetics, LLC |
|
Total Stockholders' Equity |
Balance at December 31, 2024 |
618,831 |
$ |
6,188 |
$ |
60,433 |
$ |
102,035,435 |
$ |
(89,095) |
$ |
102,012,961 |
$ |
4,994,907 |
$ |
107,007,868 |
Net income |
— |
|
— |
|
— |
|
22,883,930 |
|
— |
|
22,883,930 |
|
4,592,551 |
|
27,476,481 |
Distributions |
— |
|
— |
|
— |
|
— |
|
— |
|
— |
|
(7,797,271) |
|
(7,797,271) |
Other comprehensive income |
— |
|
— |
|
— |
|
— |
|
538,608 |
|
538,608 |
|
— |
|
538,608 |
Balance at December 31, 2025 |
618,831 |
$ |
6,188 |
$ |
60,433 |
$ |
124,919,365 |
$ |
449,513 |
$ |
125,435,499 |
$ |
1,790,187 |
$ |
127,225,686 |
The accompanying notes are an integral part of these consolidated financial statements.
5
Omnetics Connector Corporation
Consolidated Statement of Cash Flows
|
Year Ended December 31, 2025 |
|
Cash Flows from Operating Activities |
|
|
Net income |
$ |
27,476,481 |
Adjustments to reconcile net income to net cash provided by operating activities: |
|
|
Depreciation |
|
1,920,909 |
Deferred income taxes |
|
1,611,826 |
Realized gain on sale of marketable securities |
|
(6,135) |
Non-cash operating lease expense |
|
46,629 |
Unrealized loss on equity marketable securities |
|
23,269 |
Changes in operating assets and liabilities: |
|
|
Trade accounts receivable |
|
(688,703) |
Inventories |
|
(2,758,505) |
Prepaids and other assets |
|
(219,246) |
Trade accounts payable |
|
(397,797) |
Accrued expenses |
|
1,720,983 |
Net cash provided by operating activities |
|
28,729,711 |
Cash Flows used in Investing Activities |
|
|
Payments for capital expenditures |
|
(1,494,229) |
Proceeds from marketable securities |
|
10,534,873 |
Purchase of marketable securities |
|
(23,409,070) |
Net cash used in investing activities |
|
(14,368,426) |
Cash Flows used in Financing Activities |
|
|
Distributions paid from Omnetics, LLC |
|
(7,797,271) |
Net cash used in financing activities |
|
(7,797,271) |
Net Increase in Cash and Cash Equivalents |
|
6,564,014 |
Cash and Cash Equivalents - Beginning of Year |
|
22,172,044 |
Cash and Cash Equivalents - End of Year |
$ |
28,736,058 |
The accompanying notes are an integral part of these consolidated financial statements.
6
Notes to Omnetics Connector Corporation Consolidated Financial Statements
1. Summary of Significant Accounting Policies
Basis of Presentation
The accompanying consolidated financial statements include the accounts of Omnetics Connector Corporation and its wholly-owned subsidiaries (the “Company”). The Company’s financials also consolidate Omnetics, LLC, including its wholly-owned subsidiary Omnetics Global Sales, Inc., as variable interest entities as described in Note 11.
The accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (U.S. GAAP). All significant intercompany balances and transactions have been eliminated in consolidation.
Nature of Business
The Company designs and manufactures micro-miniature and nano-miniature connectors along with custom cable harnesses for the avionics, aerospace, medical, and other high technology industries.
Accounting Estimates
Management uses estimates and assumptions in preparing these consolidated financial statements in accordance with U.S. GAAP. Those estimates and assumptions affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities, and the reported revenues and expenses. Actual results could differ from those estimates and the difference could be material. Significant items subject to such estimates and assumptions include the valuation of inventory, useful lives of property and equipment, and allowance for credit losses. It is at least reasonably possible that these estimates could change in the near term.
Revenue Recognition
The Company determines revenue recognition through the following steps:
The Company derives its revenues primarily from the sale of products and recognizes revenue at a point in time when control of these products is transferred to customers, and in an amount that reflects the consideration the Company expects to be entitled to in exchange for those products. Control is generally transferred when the Company has a legal right to payment and usually occurs when products are shipped. Payment for products is usually received shortly after control of the product transfers to the customer. In certain instances, the Company will receive advances from customers. The Company records these advances as customer deposits when the cash is received and recognizes revenue as shipments are made.
The Company records reductions to revenues related to future product returns, allowances, and rebates based on the Company’s expectations and historical experience. Variable consideration is estimated at the most likely amount that is expected to be earned and is included in the transaction price to the extent it is probable that a significant reversal of cumulative revenue recognized will not occur when the uncertainty associated with the variable consideration is resolved.
Sales and other taxes collected from customers that are remitted to governmental authorities are excluded from revenues. The Company has elected to expense the incremental costs incurred to obtain a contract, as the amortization period is less than a year.
The Company applies the practical expedient in ASC 606-10-50-14 and does not disclose the transaction price allocated to unsatisfied performance obligations for contracts with an original expected duration of one year or less.
Cash and Cash Equivalents
The Company considers all highly liquid debt instruments purchased with a maturity of three months or less to be cash equivalents. The Company maintains its accounts primarily at two financial institutions. At times throughout the year, the Company’s cash and cash equivalents balances, which include cash invested in money market funds, may exceed amounts insured by the Federal Deposit Insurance Corporation. At December 31, 2025, cash equivalents were approximately $17,678,000. The Company does not believe it is exposed to any significant credit risk on cash and cash equivalents.
7
Marketable Securities
Marketable securities consist of debt and equity securities. The debt securities are comprised of corporate bonds and fixed income government securities and are considered available-for-sale and are recorded at their estimated fair value. Debt securities unrealized holding gains and losses are recorded as the difference between fair value and the amortized cost at the balance sheet date. The difference between the original cost and maturity value of a debt security is amortized to interest income. The cost of available-for-sale debt securities is determined by the specific identification method for purposes of computing unrealized and realized gains and losses. Unrealized holding gains and losses on available-for-sale debt securities are excluded from earnings and are reported as a separate component of Accumulated other comprehensive income (loss) until realized.
The equity securities are comprised of mutual funds and the Company reports any unrealized and realized gains and losses in other income on the Consolidated Statement of Operations and Comprehensive Income. The cost of equity securities is determined by the specific identification method for purposes of computing unrealized and realized gains and losses.
Marketable securities are classified as short-term or long-term in the Consolidated Balance Sheet based on their contractual maturity date or expectations regarding future sales.
The Company monitors its marketable securities to determine whether a loss exists related to the credit quality of the issuer. If the present value of the cash flows expected to be collected from the security is less than the amortized cost basis of the security, then a credit loss exists and an allowance against the security for credit losses is recorded. The allowance is limited to the amount by which fair value is below amortized cost, recognizing that the investment could be sold at fair value. Credit losses continue to be remeasured in subsequent reporting periods. When developing an estimate of expected credit losses, management considers all relevant information, including historical experience, current conditions, and reasonable forecasts of expected future cash flows. The Company is of the belief that such marketable securities will be collected in all material respects and thus, an allowance is not necessary at December 31, 2025.
Trade Accounts Receivable
Credit terms are extended to customers in the normal course of business. The Company performs ongoing credit evaluations of its customers’ financial condition, and generally requires no collateral. The Company maintains an allowance for expected credit losses on accounts receivable, which is recorded as an offset to accounts receivable. Changes in the allowance for credit losses are included as a component of Selling, general and administrative expenses in the Consolidated Statement of Operations and Comprehensive Income. The Company assesses credit losses on a collective basis where similar risk characteristics exist. Risk characteristics considered by the Company include customer type, geography, market, credit status, and age of the receivable. Receivables that do not share risk characteristics with other receivables, or where known collectability issues exist, are evaluated on an individual basis. In determining the allowance for credit losses, the Company considers historical loss rates, adjusted for current market conditions, and reasonable and supportable forecasts of future economic conditions, when applicable. Accounts considered to be uncollectible are written off against the allowance for credit losses. The Company’s allowance for credit losses was not material at December 31, 2025.
Inventories
Inventories are stated at the lower of cost or net realizable value. Cost is determined by the weighted average method. Net realizable value is the estimated selling prices in the ordinary course of business, less reasonably predictable costs of completion, disposal, and transportation.
The Company performs ongoing evaluations of all inventory for potential obsolescence. The evaluation includes analysis of historical sales and purchasing information as well as expected future product demand.
Long-Lived Assets
Property and equipment are stated at cost. Maintenance and repairs are expensed as incurred; major improvements and betterments are capitalized.
Depreciation is provided for using the straight-line method over the estimated useful lives as follows for the major classes of assets:
Asset Description Estimated Lives
Building 39 years
Office equipment, furniture and fixtures 5 years
Machinery and equipment 5 years
Leasehold improvements 5-15 years
Long-lived assets, such as property and equipment and operating lease right-of-use ("ROU") assets, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. If circumstances require a long-lived asset or asset group be tested for possible impairment, the Company first compares undiscounted cash flows expected to be generated by that asset or asset group to its carrying value. If the carrying value of the long-lived asset or asset group is not recoverable on an undiscounted cash flow basis, an impairment is recognized to the extent that the carrying value exceeds its fair value. Fair value is determined through various valuation techniques including discounted cash flow models, quoted market values, and third party independent appraisals, as considered necessary.
8
Leases
The Company determines if an arrangement is a lease at inception. A contract is or contains a lease if the contract conveys the right to control the use of an identified asset for a period of time in exchange for consideration. The right to control the use of an asset includes the right to obtain substantially all of the economic benefits of the underlying asset and the right to direct how and for what purpose the asset is used.
ROU assets represent the Company’s right to use an underlying asset for the lease term and lease liabilities represent the Company’s obligation to make lease payments arising from the lease. Variable lease payments are recognized as lease expense in the period in which the obligation for those payments is incurred. Operating lease ROU assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. The Company uses the implicit rate when readily determinable. When the rate implicit in the lease is not readily determinable, the Company uses its incremental borrowing rate based on the information available at the commencement date to determine the present value of lease payments. The operating lease ROU asset includes deferred rent previously recorded as a liability. The Company’s lease terms include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. For lease agreements that contain both lease and non-lease components, the Company generally accounts for each component separately.
Rent expense, including the effects of lease incentives, is recognized on a straight-line basis over the term of the lease.
Goodwill
Goodwill is an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. The Company does not amortize goodwill. Goodwill is tested for impairment at least annually, and more frequently whenever economic events or changes in circumstances indicate that the carrying amount of goodwill may not be recoverable. No goodwill impairment was recorded in 2025.
Income Taxes
The Company is taxed as a C corporation. As a result, the Company's taxable income is subject to federal and state income taxes at the corporate level. Therefore, a provision and liability for federal and state income taxes has been included in these consolidated financial statements.
Income taxes are provided for the tax effects of transactions reported in the consolidated financial statements and consist of taxes currently due plus deferred taxes related primarily to differences between the bases of property and equipment, deferred revenue, and certain accrued liabilities for financial and income tax reporting. The deferred tax assets and liabilities represent future tax return consequences of the book to tax differences, which will either be deductible or taxable, when the assets and liabilities are recovered or settled. Deferred taxes are also recognized in the event of operating losses that are available to offset future taxable income and tax credits that are available to offset future income taxes payable. The Company elected to account for the tax effects of the global intangible low tax income provision as a current period expense. In addition, the Company releases the income tax effects of items recorded in accumulated other comprehensive income (“AOCI”) using the aggregate portfolio approach.
The Company's accounting for uncertainty in income taxes follows the prescribed recognition threshold and measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return with either (1) an increase in liability for income taxes or a reduction of an income tax refund receivable and/or (2) a reduction in a deferred tax asset or an increase in a deferred tax liability. On an annual basis, the Company performs a review of its material tax positions in accordance with recognition and measurement standards. Based on the Company's analysis, no significant uncertain tax positions require recognition at December 31, 2025.
The Company files income tax returns in the U.S. federal jurisdiction and in various states. The Company is no longer subject to U.S. federal income tax examinations for years before 2022, with few exceptions, and is no longer subject to state income tax examinations by tax authorities for years before 2021.
Research and Development
Research and development costs are expensed as incurred. Research and development costs amounted to approximately $2,257,000 for the year ended December 31, 2025, and are included within Selling, general and administrative expenses in the Consolidated Statement of Operations and Comprehensive Income.
Variable Interest Entities
Under generally accepted accounting principles, an enterprise is required to consolidate a variable interest entity (“VIE”) in which it holds a variable interest and is the primary beneficiary of the entity. In general, a VIE is a legal entity that either (1) has an insufficient amount of equity to carry out its principal activities without additional subordinated financial support, (2) has a group of equity owners that are unable to make significant decisions about its activities, or (3) has a group of equity owners that do not have the obligation to absorb losses or the right to receive returns generated by its operations. Under the revised accounting rules, an enterprise is the primary beneficiary of a VIE, which is the party that would be required to consolidate the VIE, if it has (1) the power to direct the activities that most significantly impact the VIE's economic performance and (2) the obligation to absorb losses of the VIE or the right to receive benefits from the VIE that could be significant to the VIE. If it is a related party group that holds these characteristics rather than a single party, then it is the party within the related party group that is most closely associated with the VIE that is the primary beneficiary.
9
In determining whether it is the primary beneficiary of a VIE, the Company considers qualitative and quantitative factors and judgments, including which activities most significantly impact the VIE's economic performance and which party controls such activities; the amount and characteristics of the Company’s interests in and other involvements with the VIE; the obligation and likelihood for the Company or other investors to provide financial support to the VIE; and the similarity with and significance of the business activities of the VIE to the Company and other parties or investors involved.
Fair Value of Financial Instruments
The Company’s accounting for fair value measurements of assets and liabilities that are recognized or disclosed at fair value in the consolidated financial statements on a recurring or nonrecurring basis adheres to the Financial Accounting Standards Board (FASB) fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to measurements involving significant unobservable inputs (Level 3 measurements). The three levels of the fair value hierarchy are as follows:
The level in the fair value hierarchy within which a fair measurement in its entirety falls is based on the lowest level input that is significant to the fair value measurement in its entirety.
The carrying values of cash equivalents, trade accounts receivable, trade accounts payable, and other financial working capital items approximate fair value at December 31, 2025, due to the short maturity nature of these items.
Recently Adopted Accounting Pronouncements
In December 2023, the FASB issued ASU 2023-09, “Income Taxes (Topic 740): Improvements to Income Tax Disclosures” (“ASU 2023-09”), to enhance the transparency and decision usefulness of income tax disclosures primarily related to the tax rate reconciliation and income taxes paid information. The amendments in this ASU are effective for annual periods beginning after December 15, 2024. The Company adopted this standard in 2025 on a prospective basis, and updated its income tax note. The adoption of this accounting pronouncement did not have a material impact on the consolidated financial position or results of operations. See “Note 10. Income Taxes” for further information.
2. Concentrations, Risks, and Uncertainties
The Company's customers are predominantly major, well-established corporations that are located worldwide. Foreign sales were approximately 21% of net sales for the year ended December 31, 2025. Foreign customers represented 23% of trade accounts receivable at December 31, 2025.
One customer accounted for approximately 10% of total accounts receivable at December 31, 2025. The Company did not have any sales concentrations for the year ended December 31, 2025.
3. Inventories
Inventories consist of the following:
|
December 31, 2025 |
|
Raw materials |
$ |
22,122,210 |
Work in process |
|
11,885,679 |
Finished goods |
|
5,778,327 |
Inventories |
$ |
39,786,216 |
10
4. Marketable Securities
The amortized cost and fair value of the Company's investments in available-for-sale debt and equity securities at December 31, 2025 were as follows:
|
|
Amortized Cost |
|
Gross Unrealized Gains |
|
Gross Unrealized Losses |
|
Fair Value |
Debt Securities: |
|
|
|
|
|
|
|
|
Fixed income government securities |
$ |
30,561,864 |
$ |
387,991 |
$ |
(11,502) |
$ |
30,938,353 |
Corporate bonds |
|
12,289,900 |
|
213,764 |
|
(20,935) |
|
12,482,729 |
Total debt securities |
|
42,851,764 |
|
601,755 |
|
(32,437) |
|
43,421,082 |
Equity Securities: |
|
|
|
|
|
|
|
|
Fixed income mutual fund |
|
2,646,819 |
|
— |
|
(64,051) |
|
2,582,768 |
Total equity securities |
|
2,646,819 |
|
— |
|
(64,051) |
|
2,582,768 |
Totals |
$ |
45,498,583 |
$ |
601,755 |
$ |
(96,488) |
$ |
46,003,850 |
At December 31, 2025, gross unrealized holding gains (losses) related to marketable debt securities totaled approximately $569,000, excluding the impact of taxes. The Company recorded gross realized gains (losses) on the sale of marketable debt securities of approximately $6,000 for the year ended December 31, 2025. Other income in the Consolidated Statement of Operations and Comprehensive Income includes approximately $1,991,000 dividend and interest income for the year ended December 31, 2025.
Unrealized gains (losses) on marketable equity securities are reported in Other income on the Consolidated Statement of Operations and Comprehensive Income and totaled approximately $(23,000) for the year ended December 31, 2025.
The approximate maturities of the Company's marketable securities consist of the following:
|
December 31, 2025 |
|
Fixed income mutual fund |
|
|
Within one year |
$ |
2,582,768 |
Fixed income government securities |
|
|
Within one year |
|
15,265,987 |
One to five years |
|
15,672,366 |
Corporate bonds |
|
|
Within one year |
|
1,322,329 |
One to five years |
|
11,160,400 |
Totals |
$ |
46,003,850 |
The Company's investment in the fixed income mutual fund does not have a contractual maturity but is shown with current maturities in the table above and in the Consolidated Balance Sheet.
5. Fair Value Measurement
The following table summarizes the Company's financial instruments that were measured at fair value on a recurring basis at December 31, 2025:
|
|
|
|
Fair Value Measurement |
|||||||
|
|
Carrying Amount |
|
|
Level 1 |
|
|
Level 2 |
|
|
Level 3 |
Fixed income mutual fund |
$ |
2,582,768 |
|
$ |
2,582,768 |
|
$ |
— |
|
$ |
— |
Fixed income government securities |
|
30,938,353 |
|
|
— |
|
|
30,938,353 |
|
|
— |
Corporate bonds |
|
12,482,729 |
|
|
— |
|
|
12,482,729 |
|
|
— |
Totals |
$ |
46,003,850 |
|
$ |
2,582,768 |
|
$ |
43,421,082 |
|
$ |
— |
The mutual fund is valued by using quoted prices in an active market which are considered Level 1 inputs. Fixed income government securities and corporate bonds are valued by using quoted prices for identical or similar assets in a non-active market which are considered Level 2 inputs.
The Company recognizes transfers between levels of the fair value hierarchy at the end of the reporting period. There were no transfers into or out of Levels 1, 2, or 3 during the year ended December 31, 2025.
11
6. Property and Equipment
Property and equipment consists of the following:
|
|
December 31, 2025 |
Land and building |
$ |
2,291,175 |
Office equipment, furniture and fixtures |
|
1,919,237 |
Machinery and equipment |
|
15,626,225 |
Leasehold improvements |
|
2,044,989 |
Deposits on equipment |
|
77,199 |
Property and equipment, gross |
|
21,958,825 |
Less: accumulated depreciation |
|
(13,973,029) |
Property and equipment, net |
$ |
7,985,796 |
Depreciation expense was $1,920,909 for the year ended December 31, 2025.
7. Goodwill
The Company acquired Metric Tool & Stamping, LLC in 2023 and all of the goodwill relates to this business combination. Goodwill was $1,039,000 at December 31, 2025, and there were no changes in the carrying amount of goodwill during the year ended December 31, 2025.
8. Accrued Expenses
Accrued expenses consist of the following:
|
|
December 31, 2025 |
Accrued compensation, related benefits and taxes |
$ |
5,478,045 |
Accrued commissions |
|
1,092,661 |
Accrued income taxes |
|
1,066,105 |
Other accrued expenses |
|
21,162 |
Accrued expenses |
$ |
7,657,973 |
9. Lease Obligation
The Company has an operating lease agreement for its office and production facility that extends through March 2038. The Company has the option to renew the lease for two consecutive periods of five years each. The Company has not included the renewal options in the calculation. The Company is responsible for costs of insurance, taxes, repairs, and maintenance.
The components of lease expense consist of the following:
|
|
Year Ended December 31, 2025 |
Operating lease expense |
$ |
660,000 |
Variable lease expense |
|
607,000 |
Total lease expense |
$ |
1,267,000 |
At December 31, 2025, the estimated minimum future lease payments were as follows:
|
|
Amount |
2026 |
$ |
651,743 |
2027 |
|
667,827 |
2028 |
|
684,840 |
2029 |
|
702,162 |
2030 |
|
719,484 |
After 2030 |
|
5,778,454 |
Total lease payments |
|
9,204,510 |
Less amount representing interest |
|
(2,651,766) |
Total lease liabilities |
$ |
6,552,744 |
12
Supplemental cash flow and other information related to the lease was as follows for the year ended December 31, 2025:
Cash paid for amounts included in the measurement of lease liabilities: |
|
613,000 |
Weighted average remaining lease term – operating lease (years) |
|
12.25 |
Weighted average discount rate - operating lease |
|
5.64% |
10. Income Taxes
The income tax provision consists of the following components for the year ended December 31, 2025:
Current: |
|
|
Federal |
$ |
4,401,000 |
State |
|
1,522,000 |
Total Current Tax Expense |
|
5,923,000 |
Deferred: |
|
|
Federal |
|
1,583,000 |
State |
|
29,000 |
Total Deferred Tax Expense |
|
1,612,000 |
Total provision for income taxes |
$ |
7,535,000 |
All pre-tax income is considered domestic for the year ended December 31, 2025.
For the year ended December 31, 2025, the change in deferred taxes within the income tax provision excludes approximately $143,000 of the deferred tax asset related to unrealized gains (losses) on debt investments, which was allocated to Accumulated other comprehensive income.
In connection with becoming a public business entity, the Company presents the rate reconciliation using the specific categories required by ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures. The reconciliation of taxes at the federal statutory rate to our provision for income taxes for the year ended December 31, 2025 was as follows:
U.S. Federal Statutory Tax Rate |
$ |
7,352,000 |
|
21.00% |
State and Local Income Taxes, Net of Federal Income Tax Effect (1) |
|
1,315,000 |
|
3.77% |
Effect of Cross-Border Tax Laws |
|
|
|
|
Foreign derived intangible income deduction |
|
(38,000) |
|
(0.11)% |
Tax Credit |
|
|
|
|
Research and development tax credits |
|
(97,000) |
|
(0.28)% |
Nontaxable or Nondeductible Items |
|
|
|
|
Effect of nontaxable entity |
|
(964,000) |
|
(2.76)% |
Other adjustments |
|
5,000 |
|
0.01% |
Other Adjustments |
|
(38,000) |
|
(0.11)% |
Totals |
$ |
7,535,000 |
|
21.52% |
Cash paid for income taxes, net of refunds, during the year ended December 31, 2025, was as follows:
Federal |
$ |
5,000,000 |
California |
|
769,000 |
Other |
|
10,000 |
Total cash paid for income taxes, net of refunds |
$ |
5,779,000 |
13
The tax effects of temporary differences that give rise to significant portions of the deferred tax assets and deferred tax liabilities are presented below at December 31, 2025:
Accrued vacation |
$ |
343,000 |
Inventories |
|
679,000 |
Operating lease liabilities |
|
1,490,000 |
R&D credit |
|
516,000 |
Other assets |
|
20,000 |
Deferred tax assets |
|
3,048,000 |
|
|
|
Operating lease right of use asset |
|
(1,231,000) |
Property, plant, and equipment, net |
|
(1,152,000) |
Other liabilities |
|
(209,000) |
Deferred tax liabilities |
|
(2,592,000) |
Net deferred tax asset |
$ |
456,000 |
At December 31, 2025, the Company had federal and state capital loss carryforwards (tax effected) of approximately $16,000 and federal and state credit carryforwards (tax effected) of approximately $516,000. The federal capital loss carryforward will expire between 2027 and 2029. The state loss and credit carryforwards will expire between 2037 and 2041. Utilization of the Company’s capital loss and tax credit carryforwards may be subject to annual limitations due to the ownership change limitations provided by the Internal Revenue Code and similar state provisions. Such annual limitations could result in the expiration of state net operating loss and tax credit carryforwards before their utilization. The events that may cause ownership changes include, but are not limited to, a cumulative stock ownership change of greater than 50% over a three year period.
In evaluating the Company’s ability to recover its deferred tax assets, the Company considers all available positive and negative evidence, including its operating results, ongoing tax planning, reversal of existing temporary differences, and forecasts of future taxable income. A valuation allowance is required to be established unless management determines it is more likely than not that the Company will ultimately utilize the tax benefit associated with a deferred tax asset. At December 31, 2025, no deferred tax asset valuation allowance was considered necessary, as the Company has determined it is more likely than not that the deferred assets will be realized in future periods.
The Company remains subject to IRS examination for the 2022 through 2024 tax years. Additionally, the Company files multiple state and local income tax returns and remains subject to examination in various jurisdictions for the 2021 through 2024 tax years. The California income tax examinations for tax years 2019 and 2020 have been concluded, while the examinations for tax years 2022 and 2023 remain ongoing. The Company does not currently anticipate material additional tax liabilities related to these open examinations. At December 31, 2025, the Company did not have any unrecognized tax benefit.
On July 4, 2025, the President signed H.R. 1, the “One Big Beautiful Bill Act,” into law. The legislation includes several changes to federal tax law that generally allow for more favorable deductibility of certain business expenses beginning in 2025, including the restoration of immediate expensing of domestic research and development expenditures, reinstatement of 100% bonus depreciation, and more favorable rules for determining the limitation on business interest expense. These changes, primarily timing differences with no net impact, were incorporated in the income tax provision for the year ended December 31, 2025.
11. Variable Interest Entities
Omnetics Connector Corporation holds a variable interest in, and is the primary beneficiary of, Omnetics, LLC and its wholly-owned subsidiary, Omnetics Global Sales, Inc (the “Omnetics VIE”). This determination was primarily due to common ownership, the Company's shareholders and the members of Omnetics, LLC are the same, and the economic purpose of the Omnetics VIE. The Omnetics VIE was created to obtain tax benefits for the Company’s sales outside of the United States of America. All operating activities of the Omnetics VIE are consolidated into the financial statements of the Company and the equity interests of the Omnetics VIE not owned by the Company are presented as noncontrolling interest.
During 2025, the Company's significant transactions with the Omnetics VIE included recording commission expense totaling approximately $4,583,000.
The Company does not have any explicit liquidity arrangements or obligations to provide financial support to the Omnetics VIE beyond the commission arrangement described above. Except for the assets presented in the balance sheet below, which can be used only to settle the obligations of Omnetics VIE, the consolidated assets of the Company are not restricted for this purpose.
The balance sheet of the Omnetics VIE, before eliminations, was as follows:
|
|
December 31, 2025 |
Assets |
|
|
14
Cash |
$ |
4,080 |
Receivable from Omnetics Connector Corporation |
|
1,792,721 |
Total assets |
|
1,796,801 |
Liabilities and Members' Equity |
|
|
Members' equity |
|
1,796,801 |
Total liabilities and members' equity |
$ |
1,796,801 |
12. Employee Benefit Plans
The Company has established the Omnetics Connector Corporation 401(k) profit sharing plan for employees who have attained certain age and service requirements. The Plan is a defined contribution profit sharing plan with a 401(k) salary deferral provision. Eligible employees may elect to defer up to 100% of compensation not to exceed IRS limitations.
The Company may make discretionary profit sharing and/or safe harbor nonelective contributions. The Company made safe harbor nonelective contributions of approximately $1,052,000 for the year ended December 31, 2025. The Company also made a discretionary profit sharing contribution of approximately $400,000 for the year ended December 31, 2025.
13. Subsequent Events
On May 29, 2026, Omnetics Connector Corporation entered into an Agreement and Plan of Merger with Arxis, Inc. (the “Omnetics Merger”). The Omnetics Merger closed on August 17, 2026, with Arxis acquiring 100% of the outstanding equity of Omnetics. Preliminary purchase consideration of $777,074,416 was paid to the Company’s shareholders primarily in the form of shares of Arxis, Inc.’s Class A common stock. The consideration transferred is subject to customary closing adjustments.
The Company has evaluated subsequent events through October 29, 2026, the date the consolidated financial statements were available to be issued.
15
Exhibit 99.3
Omnetics Connector Corporation
Table of Contents
Condensed Consolidated Financial Statements |
|
Condensed Consolidated Balance Sheet |
1 |
Condensed Consolidated Statement of Operations and Comprehensive Income |
2 |
Condensed Consolidated Statement of Changes in Stockholders' Equity |
3 |
Condensed Consolidated Statement of Cash Flows |
4 |
Notes to Omnetics Connector Corporation Condensed Consolidated Financial Statements |
5-8 |
Omnetics Connector Corporation
Condensed Consolidated Balance Sheet (Unaudited)
|
|
June 30, 2026 |
Assets |
|
|
Current assets |
|
|
Cash and cash equivalents |
$ |
41,596,320 |
Marketable securities |
|
23,031,676 |
Trade accounts receivable |
|
16,476,765 |
Inventories, net |
|
44,398,216 |
Prepaid assets |
|
414,518 |
Total current assets |
|
125,917,495 |
|
|
|
Property and equipment, net |
|
7,499,179 |
Deferred income taxes |
|
566,818 |
Goodwill |
|
1,039,000 |
Operating lease right-of-use asset |
|
5,250,254 |
Other assets |
|
88,096 |
Total Assets |
$ |
140,360,842 |
|
|
|
Liabilities and Stockholders' Equity |
|
|
Current liabilities |
|
|
Trade accounts payable |
$ |
1,427,947 |
Accrued expenses |
|
9,312,183 |
Operating lease liability |
|
309,073 |
Total current liabilities |
|
11,049,203 |
Long-term portion of operating lease liability |
|
6,101,442 |
Total liabilities |
|
17,150,645 |
Stockholders' equity |
|
|
Common stock, $.01 par value; 1,000,000 shares authorized; 618,831 shares issued and outstanding at June 30, 2026 |
|
6,188 |
Additional paid-in capital |
|
60,433 |
Retained earnings |
|
119,456,820 |
Accumulated other comprehensive income |
|
32,293 |
Total stockholders' equity attributable to Omnetics Connector Corporation |
|
119,555,734 |
Noncontrolling interest – Omnetics, LLC |
|
3,654,463 |
Total stockholders' equity |
|
123,210,197 |
Total Liabilities and Stockholders' Equity |
$ |
140,360,842 |
The accompanying notes are an integral part of these condensed consolidated financial statements.
2
Omnetics Connector Corporation
Condensed Consolidated Statement of Operations and Comprehensive Income (Unaudited)
|
|
Six Months Ended June 30, 2026 |
Net sales |
$ |
66,547,727 |
Cost of products sold |
|
35,557,056 |
Gross profit |
|
30,990,671 |
Selling, general and administrative expenses |
|
9,863,263 |
Operating income |
|
21,127,408 |
Other income |
|
1,451,814 |
Income before provision for income taxes |
|
22,579,222 |
Provision for income taxes |
|
4,363,698 |
Net income |
|
18,215,524 |
Less: net income attributable to noncontrolling interest - Omnetics, LLC |
|
3,813,594 |
Net Income Attributable to Omnetics Connector Corporation |
|
14,401,930 |
Other Comprehensive Loss: |
|
|
Unrealized holding losses on marketable securities, net of tax |
|
(233,169) |
Less reclassification of gains on marketable securities included in net income, net of tax |
|
(184,051) |
Total other comprehensive loss |
|
(417,220) |
Comprehensive income attributable to Omnetics Connector Corporation |
$ |
13,984,710 |
The accompanying notes are an integral part of these condensed consolidated financial statements
1
Omnetics Connector Corporation
Condensed Consolidated Statement of Changes in Stockholders’ Equity (Unaudited)
|
Common Stock Shares |
|
Common Stock Par Value |
|
Additional Paid-in Capital |
|
Retained Earnings |
|
Accumulated Other Comprehensive Income |
|
Total Stockholders' Equity - OCC |
|
Noncontrolling Interest – Omnetics, LLC |
|
Total Stockholders' Equity |
Balance at December 31, 2025 |
618,831 |
$ |
6,188 |
$ |
60,433 |
$ |
124,919,365 |
$ |
449,513 |
$ |
125,435,499 |
$ |
1,790,187 |
$ |
127,225,686 |
Net income |
— |
|
— |
|
— |
|
14,401,930 |
|
— |
|
14,401,930 |
|
3,813,594 |
|
18,215,524 |
Distributions |
— |
|
— |
|
— |
|
(19,864,475) |
|
— |
|
(19,864,475) |
|
(1,949,318) |
|
(21,813,793) |
Other comprehensive loss |
— |
|
— |
|
— |
|
— |
|
(417,220) |
|
(417,220) |
|
— |
|
(417,220) |
Balance at June 30, 2026 |
618,831 |
$ |
6,188 |
$ |
60,433 |
$ |
119,456,820 |
$ |
32,293 |
$ |
119,555,734 |
$ |
3,654,463 |
$ |
123,210,197 |
The accompanying notes are an integral part of these condensed consolidated financial statements
2
Omnetics Connector Corporation
Condensed Consolidated Statement of Cash Flows (Unaudited)
|
|
Six Months Ended June 30, 2026 |
Cash Flows from Operating Activities |
|
|
Net income |
$ |
18,215,524 |
Adjustments to reconcile net income to net cash provided by operating activities: |
|
|
Depreciation |
|
949,920 |
Realized gain on sale of marketable securities |
|
(227,466) |
Non-cash operating lease expense |
|
17,283 |
Unrealized gain on equity marketable securities |
|
(64,051) |
Changes in operating assets and liabilities: |
|
|
Trade accounts receivable |
|
(3,452,887) |
Inventories |
|
(4,612,000) |
Prepaids and other assets |
|
547,183 |
Trade accounts payable |
|
(625,922) |
Accrued expenses |
|
1,654,210 |
Net cash provided by operating activities |
|
12,401,794 |
|
|
|
Cash Flows from Investing Activities |
|
|
Payments for capital expenditures |
|
(463,303) |
Proceeds from marketable securities |
|
23,629,724 |
Purchase of marketable securities |
|
(894,160) |
Net cash provided by investing activities |
|
22,272,261 |
|
|
|
Cash Flows used in Financing Activities |
|
|
Distributions paid from Omnetics Connector Corporation |
|
(19,864,475) |
Distributions paid from Omnetics, LLC |
|
(1,949,318) |
Net cash used in financing activities |
|
(21,813,793) |
|
|
|
Net Increase in Cash and Cash Equivalents |
|
12,860,262 |
Cash and Cash Equivalents – Beginning of Period |
|
28,736,058 |
Cash and Cash Equivalents – End of Period |
$ |
41,596,320 |
|
|
|
The accompanying notes are an integral part of these condensed consolidated financial statements
3
Notes to Omnetics Connector Corporation Condensed Consolidated Financial Statements (Unaudited)
1. Summary of Significant Accounting Policies
Basis of Presentation
The accompanying condensed consolidated financial statements include the accounts of Omnetics Connector Corporation and its wholly-owned subsidiaries, (the “Company”). The Company’s financials also consolidate Omnetics, LLC, including its wholly-owned subsidiary Omnetics Global Sales, Inc., as variable interest entities as described in Note 10. All significant intercompany balances and transactions have been eliminated in consolidation.
The accompanying condensed consolidated financial statements are unaudited and have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for interim financial information. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring adjustments) considered necessary for a fair statement of the results for the interim period have been included. These condensed consolidated financial statements should be read in conjunction with the Company's audited consolidated financial statements and related notes at and for the year ended December 31, 2025. The results of operations for the six months ended June 30, 2026 are not necessarily indicative of the results that may be expected for the full year.
Use of Estimates
The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities, and the reported amounts of revenues and expenses during the reporting period. Significant items subject to such estimates include the valuation of inventory, useful lives of property and equipment, and the allowance for credit losses. Actual results could differ from those estimates.
Significant Accounting Policies
There have been no material changes to the Company’s significant accounting policies from those described in the audited consolidated financial statements for the year ended December 31, 2025.
Research and Development
Research and development costs are expensed as incurred. Research and development costs amounted to approximately $1,129,000 for the six months ended June 30, 2026, and are included within Selling, general and administrative expenses in the Condensed Consolidated Statement of Operations and Comprehensive Income.
2. Concentrations, Risks, and Uncertainties
The Company's customers are predominantly major, well-established corporations that are located worldwide. Foreign sales were approximately 18% of net sales for the six months ended June 30, 2026. Foreign customers represented approximately 32% of trade accounts receivable at June 30, 2026.
The Company did not have any sales concentrations for the six months ended June 30, 2026. All of the Company's revenue from contracts with customers for the six months ended June 30, 2026 was recognized at a point in time when control transferred to customers, generally upon shipment in accordance with the applicable contractual terms.
The Company did not have any accounts receivable concentrations at June 30, 2026. The Company's allowance for credit losses was not material at June 30, 2026.
3. Inventories
Inventories consist of the following:
|
|
June 30, 2026 |
Raw materials |
$ |
20,803,367 |
Work in process |
|
17,696,804 |
Finished goods |
|
5,898,045 |
Inventories |
$ |
44,398,216 |
4
4. Marketable Securities
The amortized cost and fair value of the Company's investments in available-for-sale debt at June 30, 2026 were as follows:
|
|
Amortized Cost |
|
Gross Unrealized Gains |
|
Gross Unrealized Losses |
|
Fair Value |
Debt Securities: |
|
|
|
|
|
|
|
|
Fixed income government securities |
$ |
22,823,140 |
$ |
118,396 |
$ |
(82,016) |
$ |
22,859,520 |
Corporate bonds |
|
167,345 |
|
4,811 |
|
— |
|
172,156 |
Totals |
$ |
22,990,485 |
$ |
123,207 |
$ |
(82,016) |
$ |
23,031,676 |
At June 30, 2026, gross unrealized holding gains (losses) related to marketable debt securities totaled approximately $41,000, excluding the impact of taxes. The Company reviewed its available-for-sale securities in an unrealized loss position and concluded that the decline in fair value was not related to credit losses and is recoverable. The Company recorded gross realized gains (losses) on the sale of marketable securities of approximately $227,000 for the six months ended June 30, 2026. Other income in the Condensed Consolidated Statement of Operations and Comprehensive Income includes approximately $1,174,000 of dividend and interest income for the six months ended June 30, 2026.
The approximate maturities of the Company's marketable securities consist of the following:
|
June 30, 2026 |
|
Fixed income government securities |
|
|
Within one year |
$ |
11,861,942 |
One to five years |
|
10,997,578 |
Corporate bonds |
|
|
Within one year |
|
— |
One to five years |
|
172,156 |
Totals |
$ |
23,031,676 |
Although certain of the Company's marketable debt securities have contractual maturities beyond one year, the Company considers all of its marketable securities to be available for use in current operations and, accordingly, has classified all marketable securities as current assets in the Condensed Consolidated Balance Sheet at June 30, 2026.
5. Fair Value Measurement
The following table summarizes the Company's financial instruments that were measured at fair value on a recurring basis at June 30, 2026:
|
|
|
Fair Value Measurement |
|||||
|
|
Carrying Amount |
|
Level 1 |
|
Level 2 |
|
Level 3 |
Fixed income government securities |
$ |
22,859,520 |
$ |
— |
$ |
22,859,520 |
$ |
— |
Corporate bonds |
|
172,156 |
|
— |
|
172,156 |
|
— |
Totals |
$ |
23,031,676 |
$ |
— |
$ |
23,031,676 |
$ |
— |
The fixed income government securities and corporate bonds are valued by using quoted prices for identical or similar assets in a non-active market which are considered Level 2 inputs.
The Company recognizes transfers between levels of the fair value hierarchy at the end of the reporting period. There were no transfers into or out of Levels 1, 2, or 3 during the six months ended June 30, 2026.
5
6. Property and Equipment
Property and equipment consists of the following:
|
June 30, 2026 |
|
Land and building |
$ |
2,291,175 |
Office equipment, furniture and fixtures |
|
1,939,656 |
Machinery and equipment |
|
16,146,308 |
Leasehold improvements |
|
2,044,989 |
Property and equipment, gross |
|
22,422,128 |
Less: accumulated depreciation |
|
(14,922,949) |
Property and equipment, net |
$ |
7,499,179 |
Depreciation expense was $949,920 for the six months ended June 30, 2026.
7. Goodwill
The Company acquired Metric Tool & Stamping, LLC in 2023 and all of the goodwill relates to this business combination. Goodwill was $1,039,000 at June 30, 2026, and there were no changes in the carrying amount of goodwill during the six months ended June 30, 2026.
8. Accrued Expenses
Accrued expenses consist of the following:
|
|
June 30, 2026 |
Accrued compensation, related benefits and taxes |
$ |
5,156,748 |
Accrued income taxes |
|
3,095,939 |
Accrued commissions |
|
1,055,019 |
Other accrued expenses |
|
4,477 |
Accrued expenses |
$ |
9,312,183 |
9. Income Taxes
The Company is taxed as a C corporation. The provision for income taxes for interim periods is determined using an estimate of the Company's annual effective tax rate, adjusted for discrete items recognized in the period. The Company's effective tax rate for the six months ended June 30, 2026 was approximately 19.33%, which differs from the federal statutory rate of 21% primarily due to state income taxes, the foreign-derived intangible income deduction, research and development credits, and the effect of income attributable to the nontaxable entity. No significant uncertain tax positions require recognition at June 30, 2026.
10. Variable Interest Entities
Omnetics Connector Corporation holds a variable interest in, and is the primary beneficiary of, Omnetics, LLC and its wholly-owned subsidiary, Omnetics Global Sales, Inc (the “Omnetics VIE”). This determination was primarily due to common ownership, the Company's shareholders and the members of Omnetics, LLC are the same, and the economic purpose of the Omnetics VIE. The Omnetics VIE was created to obtain tax benefits for the Company’s sales outside of the United States of America. All operating activities of the Omnetics VIE are consolidated into the financial statements of the Company and the equity interests of the Omnetics VIE not owned by the Company are presented as noncontrolling interest.
During the six months ended June 30, 2026, the Company recorded commission expense to the Omnetics VIE of approximately $3,814,000, which is eliminated in consolidation.
The Company does not have any explicit liquidity arrangements or obligations to provide financial support to Omnetics, LLC or Omnetics Global Sales, Inc. beyond the commission arrangement described above. Except for the assets presented in the balance sheet below, which can be used only to settle the obligations of Omnetics, LLC and its subsidiary, the consolidated assets of the Company are not restricted for this purpose.
6
The condensed balance sheet of the Omnetics VIE, before eliminations, was as follows:
|
|
June 30, 2026 |
Assets |
|
|
Cash |
$ |
3,925 |
Receivable from Omnetics Connector Corporation |
|
3,654,619 |
Total assets |
|
3,658,544 |
Liabilities and Members' Equity |
|
|
Members' equity |
|
3,658,544 |
Total liabilities and members' equity |
$ |
3,658,544 |
11. Employee Benefit Plans
The Company has established the Omnetics Connector Corporation 401(k) profit sharing plan for employees who have attained certain age and service requirements. The Plan is a defined contribution profit sharing plan with a 401(k) salary deferral provision. Eligible employees may elect to defer up to 100% of compensation not to exceed IRS limitations. The Company may make discretionary profit sharing and/or safe harbor nonelective contributions. The Company made safe harbor nonelective contributions of approximately $613,000 for the six months ended June 30, 2026. The Company also made a discretionary profit sharing contribution of approximately $200,000 for the six months ended June 30, 2026.
12. Subsequent Events
On May 29, 2026, Omnetics Connector Corporation entered into an Agreement and Plan of Merger with Arxis, Inc (the “Omnetics Merger”). The Omnetics Merger closed on August 17, 2026, with Arxis acquiring 100% of the outstanding equity of Omnetics. Preliminary purchase consideration of $777,074,416 was paid to the Company's shareholders primarily in the form of shares of Arxis, Inc’s Class A common stock. The consideration transferred is subject to customary closing adjustments.
The Company has evaluated subsequent events through October 29, 2026, the date the condensed consolidated financial statements were available to be issued.
7
Exhibit 99.4
UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION
On August 17, 2026 (the “Closing Date”), Arxis, Inc. (“Arxis” or the “Company”) completed the previously announced acquisition of Omnetics Connector Corporation (“Omnetics”) pursuant to the Agreement and Plan of Merger (the “Omnetics Merger”).
The following unaudited pro forma condensed combined financial information was prepared in accordance with the requirements of Article 11 of Regulation S-X and gives effect to the Omnetics Merger (the “Transaction Accounting Adjustments”, as described below in "Note 1. Description of the Omnetics Merger and Basis of Presentation”) as if it had occurred on January 1, 2025 for purposes of the unaudited pro forma condensed combined statements of operations for the nine months ended September 30, 2026 and for the year ended December 31, 2025.
The unaudited pro forma condensed combined financial information gives pro forma effect only to the Omnetics Merger and does not give pro forma effect to any other transactions completed by the Company during 2026, except as described in Note 2(g) with respect to the determination of pro forma weighted-average common shares outstanding. The results of such other transactions are included in the historical results of the Company from their respective transaction dates.
In accordance with Rule 11-02(c)(1) of Regulation S-X, the unaudited pro forma condensed combined financial information is not required to, and does not, include an unaudited pro forma condensed combined balance sheet as of September 30, 2026 because the Omnetics Merger is already reflected in the Company’s historical condensed consolidated balance sheet as of September 30, 2026, included in the Company’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2026, filed with the Securities and Exchange Commission (“SEC”) on October 29, 2026.
The unaudited pro forma condensed combined financial information was prepared in accordance with Article 11 of Regulation S-X using accounting policies in accordance with U.S. Generally Accepted Accounting Principles (“U.S. GAAP”). The unaudited pro forma condensed combined financial information: (1) was prepared using the acquisition method of accounting pursuant to Accounting Standards Codification 805, Business Combinations (“ASC 805”), with the Company being the accounting acquirer, and (2) has been adjusted to give pro forma effect to the historical consolidated financial statements of the Company and Omnetics to account for the Omnetics Merger.
In accordance with ASC 805, the Company used its best estimates and assumptions to assign fair values to the tangible and identifiable intangible assets acquired and liabilities assumed, and to the related income tax impacts as of the Closing Date. The estimated excess of the purchase price over the fair value of identifiable assets acquired and liabilities assumed was allocated to goodwill. The estimated fair values of the assets acquired and liabilities assumed are considered preliminary and are based on the information that was available as of the Closing Date. Actual future results of the combined company may differ significantly from the pro forma amounts presented here due to various factors, including differences between the preliminary purchase price allocation and the final allocation, future business performance, integration efforts, and market conditions. The unaudited pro forma condensed combined financial information reflects all material adjustments necessary to be in accordance with Article 11 of Regulation S-X and is based on available information and certain assumptions we believe are reasonable but are subject to change.
The unaudited pro forma condensed combined financial information is presented for illustrative purposes only. Such information is not necessarily indicative of the operating results or financial position that would have been achieved if the Omnetics Merger had been consummated on the date indicated, or that the combined company may achieve in future periods. Further, the unaudited pro forma condensed combined financial information does not reflect any revenue and operating synergies or cost savings that may result from the Omnetics Merger.
The unaudited pro forma condensed combined financial information and related notes are derived from:
ARXIS, INC.
UNAUDITED PRO FORMA CONDENSED COMBINED STATEMENT OF OPERATIONS
For the Nine Months Ended September 30, 2026
(in thousands, except per share data)
|
|
|
Historical Omnetics |
|
|
|
|
|
|
|||||||||
|
Historical Arxis(1) |
|
Period from January 1 to June 30, 2026 |
|
Period from July 1 to August 16, 2026 |
|
Transaction Accounting Adjustments |
|
Note 2 |
|
Pro Forma Arxis |
|||||||
Revenue |
$ |
1,523,565 |
|
$ |
66,548 |
|
$ |
18,232 |
|
$ |
— |
|
|
|
$ |
1,608,345 |
||
Cost of revenue |
|
720,036 |
|
|
35,557 |
|
|
9,242 |
|
|
(4,828) |
|
(a), (c), (d) |
|
|
760,007 |
||
Gross profit |
|
803,529 |
|
|
30,991 |
|
|
8,990 |
|
|
4,828 |
|
|
|
|
848,338 |
||
Selling, general and administrative expenses |
|
413,913 |
|
|
9,864 |
|
|
2,991 |
|
|
6 |
|
(a), (c) |
|
|
426,774 |
||
Amortization of intangible assets |
|
113,001 |
|
|
— |
|
|
— |
|
|
15,437 |
|
(b) |
|
|
128,438 |
||
Operating income (loss) |
|
276,615 |
|
|
21,127 |
|
|
5,999 |
|
|
(10,615) |
|
|
|
|
293,126 |
||
Interest expense, net |
|
101,273 |
|
|
— |
|
|
— |
|
|
— |
|
|
|
|
101,273 |
||
Other income, net |
|
(11,990) |
|
|
(1,452) |
|
|
(106) |
|
|
— |
|
|
|
|
(13,548) |
||
Net income (loss) before income taxes |
|
187,332 |
|
|
22,579 |
|
|
6,105 |
|
|
(10,615) |
|
|
|
|
205,401 |
||
Income tax expense (benefit) |
|
55,219 |
|
|
4,363 |
|
|
1,189 |
|
|
(1,324) |
|
(f) |
|
|
59,447 |
||
Net income (loss) |
|
132,113 |
|
|
18,216 |
|
|
4,916 |
|
|
(9,291) |
|
|
|
|
145,954 |
||
Less: Net income (loss) attributable to noncontrolling interest |
|
— |
|
|
3,814 |
|
|
494 |
|
|
(4,308) |
|
(e) |
|
|
— |
||
Net income (loss) attributable to Arxis |
$ |
132,113 |
|
$ |
14,402 |
|
$ |
4,422 |
|
$ |
(4,983) |
|
|
|
$ |
145,954 |
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||
Income (loss) per share |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||
Basic |
$ |
0.19 |
|
|
|
|
|
|
|
|
|
|
(g) |
|
$ |
0.34 |
||
Diluted |
$ |
0.19 |
|
|
|
|
|
|
|
|
|
|
(g) |
|
$ |
0.34 |
||
Number of shares used in computing income (loss) per share: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||
Basic |
|
409,073 |
|
|
|
|
|
|
|
|
|
|
(g) |
|
|
422,895 |
||
Diluted |
|
419,211 |
|
|
|
|
|
|
|
|
|
|
(g) |
|
|
433,033 |
||
See the accompanying notes to the Unaudited Pro Forma Condensed Combined Financial Information.
2
ARXIS, INC.
UNAUDITED PRO FORMA CONDENSED COMBINED STATEMENT OF OPERATIONS
For the Year Ended December 31, 2025
(in thousands, except per share data)
|
|
Historical Arxis |
|
Historical Omnetics |
|
Transaction Accounting Adjustments |
|
Note 2 |
|
Pro Forma Arxis |
||||
Revenue |
|
$ |
1,591,020 |
|
$ |
113,518 |
|
$ |
— |
|
|
|
$ |
1,704,538 |
Cost of revenue |
|
|
836,304 |
|
|
64,588 |
|
|
8,465 |
|
(a), (c), (d) |
|
|
909,357 |
Gross profit |
|
|
754,716 |
|
|
48,930 |
|
|
(8,465) |
|
|
|
|
795,181 |
Selling, general and administrative expenses |
|
|
339,081 |
|
|
15,947 |
|
|
33 |
|
(a), (c), (e) |
|
|
355,061 |
Amortization of intangible assets |
|
|
138,937 |
|
|
— |
|
|
24,659 |
|
(b) |
|
|
163,596 |
Operating income (loss) |
|
|
276,698 |
|
|
32,983 |
|
|
(33,157) |
|
|
|
|
276,524 |
Interest expense, net |
|
|
220,316 |
|
|
— |
|
|
— |
|
|
|
|
220,316 |
Other income, net |
|
|
(5,932) |
|
|
(2,029) |
|
|
— |
|
|
|
|
(7,961) |
Net income (loss) before income taxes |
|
|
62,314 |
|
|
35,012 |
|
|
(33,157) |
|
|
|
|
64,169 |
Income tax expense (benefit) |
|
|
16,325 |
|
|
7,535 |
|
|
(5,998) |
|
(f) |
|
|
17,862 |
Net income (loss) |
|
|
45,989 |
|
|
27,477 |
|
|
(27,159) |
|
|
|
|
46,307 |
Less: Net income (loss) attributable to noncontrolling interest |
|
|
— |
|
|
4,593 |
|
|
(4,593) |
|
(e) |
|
|
— |
Net income (loss) attributable to Arxis |
|
$ |
45,989 |
|
$ |
22,884 |
|
$ |
(22,566) |
|
|
|
$ |
46,307 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) per share |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic |
|
|
N/A |
|
|
|
|
|
|
|
(g) |
|
$ |
0.11 |
Diluted |
|
|
N/A |
|
|
|
|
|
|
|
(g) |
|
$ |
0.11 |
Number of shares used in computing net income (loss) per share: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic |
|
|
N/A |
|
|
|
|
|
|
|
(g) |
|
|
422,775 |
Diluted |
|
|
N/A |
|
|
|
|
|
|
|
(g) |
|
|
432,913 |
See the accompanying notes to the Unaudited Pro Forma Condensed Combined Financial Information.
3
NOTES TO THE UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION
Note 1. Description of the Omnetics Merger and Basis of Presentation
The unaudited pro forma condensed combined financial information was prepared in accordance with Article 11 of Regulation S-X, as amended by the final rule, Release No. 33-10786 “Amendments to Financial Disclosures about Acquired and Disposed Businesses,” and presents the unaudited pro forma condensed combined statements of operations for the nine months ended September 30, 2026, and for the year ended December 31, 2025, which combine the historical statements of operations of Arxis and Omnetics, giving effect to the Omnetics Merger as if it had occurred on January 1, 2025.
The unaudited pro forma combined statements of operations combine the results of operations of Arxis for the nine months ended September 30, 2026 (which includes the results of Omnetics starting August 17, 2026) with the results of operations of Omnetics for the six months ended June 30, 2026 and for the period from July 1, 2026 to August 16, 2026.
The Omnetics Merger
On May 29, 2026, the Company entered into an Agreement and Plan of Merger (the “Merger Agreement”) to acquire Omnetics. Omnetics is a leading designer and manufacturer of proprietary high-reliability Micro-D-Sub and Nano-D-Sub connectors and interconnect assemblies used in critical defense and space, commercial aerospace and medical applications and operates within the Company’s Electronic Components segment.
On August 17, 2026, the Company closed the Omnetics Merger. The aggregate consideration for the Merger was based on an agreed enterprise value, which was $770.0 million, subject to customary closing adjustments. At closing, the Company issued 13,351,964 shares of the Company’s Class A common stock, par value $0.01 per share (“Class A common stock”), to the former shareholders of Omnetics and funded $8.0 million of cash escrow accounts pursuant to the Merger Agreement.
The unaudited pro forma condensed combined financial information has been prepared to illustrate the effects of the Omnetics Merger. Under the acquisition method of accounting, in accordance with ASC 805, the assets and liabilities of Omnetics, at the Closing Date, were recorded at their estimated fair values and any excess of the consideration transferred over the fair value of Omnetics’ net assets was allocated to goodwill. The assets and liabilities of Omnetics have been measured based on various estimates, based on information that is currently available. The results of operations of Omnetics are included within the Company’s results of operations prospectively from the Closing Date.
The unaudited pro forma condensed combined financial data does not reflect any cost savings, operating synergies, or revenue enhancements from the Omnetics Merger.
Preliminary Consideration Transferred
The total preliminary consideration transferred is calculated as follows (in thousands, except per share data):
Shares of Arxis Class A common stock issued |
|
13,352 |
Price per share of Arxis Class A common stock(1) |
$ |
57.60 |
Fair value of shares issued |
$ |
769,073 |
Cash consideration(2) |
$ |
8,001 |
Total consideration transferred |
$ |
777,074 |
Preliminary Purchase Price Allocation
The preliminary consideration transferred was allocated to the identifiable assets acquired and liabilities assumed of Omnetics based on their preliminary estimated fair values and consisted of total assets acquired of $914.0 million, including $462.0 million of intangible assets, $354.6 million of goodwill, $52.5 million of inventories, and $44.9 million of all other current and non-current assets, with $136.9 million of assumed total liabilities, which includes $115.7 million of deferred tax liabilities.
Goodwill is calculated as the excess of the total consideration transferred over the estimated fair value of the net assets acquired. The goodwill is attributable to synergies and economies of scale expected from combining the operations of Arxis and Omnetics.
4
Note 2. Notes to Unaudited Pro Forma Condensed Combined Statements of Operations
Transaction Accounting Adjustments include the following adjustments related to the unaudited pro forma condensed combined statements of operations for the nine months ended September 30, 2026 and for the year ended December 31, 2025, as follows:
|
|
Period from January 1, 2026 to August 16, 2026 |
||||||
(in thousands) |
|
Historical |
|
|
Pro Forma |
|
|
Pro Forma |
Cost of revenue |
$ |
— |
|
$ |
105 |
|
$ |
105 |
Selling, general and administrative expenses |
|
— |
|
|
21 |
|
|
21 |
Total amortization expense |
$ |
— |
|
$ |
126 |
|
$ |
126 |
|
|
Year Ended December 31, 2025 |
||||||
(in thousands) |
|
Historical |
|
|
Pro Forma |
|
|
Pro Forma |
Cost of revenue |
$ |
— |
|
$ |
169 |
|
$ |
169 |
Selling, general and administrative expenses |
|
— |
|
|
32 |
|
|
32 |
Total amortization expense |
$ |
— |
|
$ |
201 |
|
$ |
201 |
|
|
Period from January 1, 2026 to August 16, 2026 |
||||||
(in thousands) |
|
Historical |
|
|
Pro Forma |
|
|
Pro Forma |
Amortization of intangible assets |
$ |
— |
|
$ |
15,437 |
|
$ |
15,437 |
|
|
Year Ended December 31, 2025 |
||||||
(in thousands) |
|
Historical |
|
|
Pro Forma |
|
|
Pro Forma |
Amortization of intangible assets |
$ |
— |
|
$ |
24,659 |
|
$ |
24,659 |
|
|
Period from January 1, 2026 to August 16, 2026 |
||||||
(in thousands) |
|
Historical |
|
|
Pro Forma |
|
|
Pro Forma |
Cost of revenue |
$ |
1,138 |
|
$ |
(85) |
|
$ |
1,053 |
Selling, general and administrative expenses |
|
123 |
|
|
(15) |
|
|
108 |
Total depreciation expense |
$ |
1,261 |
|
$ |
(100) |
|
$ |
1,161 |
5
|
|
Year Ended December 31, 2025 |
||||||
(in thousands) |
|
Historical |
|
|
Pro Forma |
|
|
Pro Forma Depreciation |
Cost of revenue |
$ |
1,738 |
|
$ |
(57) |
|
$ |
1,681 |
Selling, general and administrative expenses |
|
182 |
|
|
(9) |
|
|
173 |
Total depreciation expense |
$ |
1,920 |
|
$ |
(66) |
|
$ |
1,854 |
|
|
Nine Months Ended September 30, 2026 |
||||||
(in thousands) |
|
Historical |
|
|
Pro Forma |
|
|
Pro Forma |
Cost of revenue |
$ |
4,848 |
|
$ |
(4,848) |
|
$ |
— |
|
|
Year Ended December 31, 2025 |
||||||
(in thousands) |
|
Historical |
|
|
Pro Forma |
|
|
Pro Forma |
Cost of revenue |
$ |
— |
|
$ |
8,353 |
|
$ |
8,353 |
|
|
Period from January 1, 2026 to August 16, 2026 |
||||||
(in thousands) |
|
Historical |
|
|
Pro Forma |
|
|
Pro Forma |
Net income (loss) attributable to noncontrolling interest |
$ |
4,308 |
|
$ |
(4,308) |
|
$ |
— |
|
|
Year Ended December 31, 2025 |
||||||
(in thousands) |
|
Historical |
|
|
Pro Forma |
|
|
Pro Forma |
Selling, general and administrative expenses |
$ |
(10) |
|
$ |
10 |
|
$ |
— |
Net income (loss) attributable to noncontrolling interest |
|
4,593 |
|
|
(4,593) |
|
|
— |
Because Arxis did not have common stock outstanding prior to the Reorganization, pro forma weighted-average common shares outstanding for both periods include the shares issued in the Reorganization and the IPO (as described and defined within the Company’s final prospectus filed with the SEC pursuant to Rule 424(b)(4) on April 16, 2026) as if issued on January 1, 2025, reflecting the Company’s capital structure at the time of the Omnetics Merger. The Reorganization and the IPO are reflected solely in pro forma weighted-average common shares outstanding for purposes of determining pro forma net income per share. Shares of common stock issued upon the vesting of restricted stock awards (“RSAs”) and restricted stock units (“RSUs”) granted in connection with the Reorganization are included in pro forma basic weighted-average common shares outstanding from their
6
respective vesting dates. Unvested RSAs and RSUs are excluded from pro forma basic weighted-average common shares outstanding.
The Company’s share of convertible common stock is a participating security. Accordingly, pro forma basic net income per share is calculated using the two-class method, under which pro forma net income is allocated to the convertible common stock based on its contractual right to participate in dividends on an as-converted basis, determined using shares outstanding as of September 30, 2026. For pro forma diluted net income per share, the Company applied the if-converted method, which was more dilutive than the two-class method for both periods presented.
Pro forma diluted weighted-average common shares outstanding include the dilutive effect of unvested RSAs and RSUs granted in connection with the Reorganization and the convertible common stock as if such instruments had been outstanding for the entirety of each period presented. The dilutive effect of unvested RSAs and RSUs was calculated using the treasury stock method based on the Company’s computation for the period from April 1, 2026 through September 30, 2026 in its historical financial statements. Because the Company’s Class A common stock was not publicly traded prior to the IPO, the same incremental shares were applied to the year ended December 31, 2025. The dilutive effect of the convertible common stock was calculated under the if-converted method as of September 30, 2026, consistent with the Company’s diluted net income per share for the nine months ended September 30, 2026.
The following table summarizes the computation of the unaudited pro forma net income per share, basic and diluted:
(in thousands, except per share data) |
For the Nine Months Ended September 30, 2026 |
|
For the Year Ended December 31, 2025 |
||
Numerator: |
|
|
|
|
|
Pro forma combined net income |
$ |
145,954 |
|
$ |
46,307 |
Less: net income allocated to convertible common stock |
|
(1,714) |
|
|
(544) |
Pro forma net income attributable to common stockholders, basic |
$ |
144,240 |
|
$ |
45,763 |
Plus: net income allocated to convertible common stock(1) |
|
1,714 |
|
|
544 |
Pro forma net income attributable to common stockholders, diluted |
$ |
145,954 |
|
$ |
46,307 |
Denominator: |
|
|
|
|
|
Common stock issued in our Reorganization and IPO in April 2026(2) |
|
409,423 |
|
|
409,423 |
Shares issued in connection with the Omnetics Merger |
|
13,352 |
|
|
13,352 |
Weighted-average shares for vested RSAs and RSUs post-April 2026 |
|
120 |
|
|
— |
Pro Forma weighted-average common shares outstanding, basic |
|
422,895 |
|
|
422,775 |
Effect of dilutive securities, restricted shares and restricted stock units |
|
5,109 |
|
|
5,109 |
Effect of dilutive securities, convertible common stock(1) |
|
5,029 |
|
|
5,029 |
Pro Forma weighted-average common shares outstanding, diluted |
|
433,033 |
|
|
432,913 |
|
|
|
|
|
|
Pro forma net income per share, basic |
$ |
0.34 |
|
$ |
0.11 |
Pro forma net income per share, diluted |
$ |
0.34 |
|
$ |
0.11 |
7